Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Names Vysis Chief to Be CEO

NEW YORK, April 15 - Cepheid said today it has hired John L. Bishop to be CEO.

Bishop, who will also become a member of Cepheid's board, succeeds co-founder Thomas L. Gutshall, who will continue as chairman.


"Clinical diagnostics represents a major untapped opportunity for Cepheid's DNA testing products, and John's outstanding record of success in creating and expanding new markets will be a tremendous asset," Gutshall said in a statement.

Before joining Cepheid, Bishop was president and CEO of Vysis, which he helped create. Bishop took the company public in 1998, and oversaw its sale to Abbott Laboratories in December 2001 for roughly $355 million.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.